Brief: CSL Announces Expansion Of Illinois Plasma Therapy Manufacturing Facility
09/03/2026 15:00
March 9 (Reuters) - CSL Ltd CSL.AX: CSL: ANNOUNCES EXPANSION OF ILLINOIS PLASMA THERAPY MANUFACTURING FACILITY CSL: KANKAKEE ILLINOIS FACILITY EXPANSION, EXPECTED TO BE OPERATIONAL BY 2031 CSL: EXPANSION WILL CREATE AT LEAST 300 NEW PHARMACEUTICAL ROLES Further company coverage: CSL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Csl
See all newsEU Commission opens antitrust probe into Sanofi's flu vaccine campaign (updated)
EU Commission opens antitrust probe into Sanofi's flu vaccine campaign
Analysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
US military requires flu vaccine for some after outbreak in Texas training center
Corrected: BUZZ-Australian healthcare stocks hit a six-week high, acting as a primary hedge on ASX